Skip to main content

Perspective Therapeutics Inc

For the period ended Jun 30, 2024. Filed Aug 13, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 13, 2024

CATX$0.84+6.5%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

PERSPECTIVE THERAPEUTICS, INC., a Delaware corporation

/s/ Johan (Thijs) Spoor

Johan (Thijs) Spoor

Chief Executive Officer(Principal Executive Officer)

/s/ Jonathan Hunt

Jonathan Hunt

Chief Financial Officer(Co-Principal Financial Officer)

/s/ Mark J. Austin

Mark J. Austin

Vice President of Finance and Corporate Controller(Co-Principal Financial Officer, Principal Accounting Officer, Corporate Secretary)

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.